The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network
- PMID: 20922462
- DOI: 10.1007/s10555-010-9257-9
The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network
Abstract
The tumor suppressor p53 homologues, TA-p73, and p63 have been shown to function as tumor suppressors. However, how they function as tumor suppressors remains elusive. Here, I propose a number of tumor suppressor pathways that illustrate how the TA-p73 and p63 could function as negative regulators of invasion, metastasis, and cancer stem cells (CSCs) proliferation. Furthermore, I provide molecular insights into how TA-p73 and p63 could function as tumor suppressors. Remarkably, the guardians--p53, p73, and p63--of the genome are in control of most of the known tumor suppressor miRNAs, tumor suppressor genes, and metastasis suppressors by suppressing c-myc through miR-145/let-7/miR-34/TRIM32/PTEN/FBXW7. In particular, p53 and TA-p73/p63 appear to upregulate the expression of (1) tumor suppressor miRNAs, such as let-7, miR-34, miR-15/16a, miR-145, miR-29, miR-26, miR-30, and miR-146a; (2) tumor suppressor genes, such as PTEN, RBs, CDKN1a/b/c, and CDKN2a/b/c/d; (3) metastasis suppressors, such as Raf kinase inhibitory protein, CycG2, and DEC2, and thereby they enlarge their tumor suppressor network to inhibit tumorigenesis, invasion, angiogenesis, migration, metastasis, and CSCs proliferation.
Similar articles
-
The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex.PLoS One. 2010 May 12;5(5):e10615. doi: 10.1371/journal.pone.0010615. PLoS One. 2010. PMID: 20485546 Free PMC article.
-
A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.J Clin Invest. 2011 Feb;121(2):809-20. doi: 10.1172/JCI43897. J Clin Invest. 2011. PMID: 21293058 Free PMC article.
-
Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.Int J Cancer. 2002 May 1;99(1):22-8. doi: 10.1002/ijc.10296. Int J Cancer. 2002. PMID: 11948487
-
p63 and p73: roles in development and tumor formation.Mol Cancer Res. 2004 Jul;2(7):371-86. Mol Cancer Res. 2004. PMID: 15280445 Review.
-
The p53/p63/p73 family of transcription factors: overlapping and distinct functions.J Cell Sci. 2000 May;113 ( Pt 10):1661-70. doi: 10.1242/jcs.113.10.1661. J Cell Sci. 2000. PMID: 10769197 Review.
Cited by
-
p53, a translational regulator: contribution to its tumour-suppressor activity.Oncogene. 2015 Oct 29;34(44):5513-23. doi: 10.1038/onc.2015.25. Epub 2015 Mar 2. Oncogene. 2015. PMID: 25728674 Review.
-
Clinical and prognostic significance of miR-155 and miR-146a expression levels in formalin-fixed/paraffin-embedded tissue of patients with diffuse large B-cell lymphoma.Exp Ther Med. 2012 May;3(5):763-770. doi: 10.3892/etm.2012.502. Epub 2012 Mar 2. Exp Ther Med. 2012. PMID: 22969965 Free PMC article.
-
DICER: structure, function, and regulation.Biophys Rev. 2021 Nov 16;13(6):1081-1090. doi: 10.1007/s12551-021-00902-w. eCollection 2021 Dec. Biophys Rev. 2021. PMID: 35059029 Free PMC article. Review.
-
ΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transition.Oncotarget. 2017 Jan 10;8(2):2114-2129. doi: 10.18632/oncotarget.13797. Oncotarget. 2017. PMID: 27924063 Free PMC article. Review.
-
Mutant p53 regulates Dicer through p63-dependent and -independent mechanisms to promote an invasive phenotype.J Biol Chem. 2014 Jan 3;289(1):122-32. doi: 10.1074/jbc.M113.502138. Epub 2013 Nov 12. J Biol Chem. 2014. PMID: 24220032 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous